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Voxel-based morphometry analysis reveals frontal 
brain differences in participants with ADHD and their 
unaffected siblings
Janita Bralten, PhD*; Corina U. Greven, PhD*; Barbara Franke, PhD; Maarten Mennes, PhD; 
Marcel P. Zwiers, PhD; Nanda N.J. Rommelse, PhD; Catharina Hartman, PhD;  
Dennis van der Meer, MS; Laurence O’Dwyer, PhD; Jaap Oosterlaan, MD, PhD;  
Pieter J. Hoekstra, PhD; Dirk Heslenfeld, PhD; Alejandro Arias-Vasquez, PhD;  
Jan K. Buitelaar, MD, PhD
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a common 
neuropsychiatric disorder characterized by developmentally 
inappropriate impulsive, hyperactive and/or inattentive symp-
toms.1 Previous MRI studies have reported smaller total brain 
volumes in participants with ADHD than in controls.2,3 Meta-
analyses of regions of interest (ROI) studies have shown signifi-
cantly smaller volume in total and right cerebral volume, fron-
tal brain areas, the right caudate and cerebellar regions in 
participants with ADHD than in controls.3 Volumetric ROI 
studies, however, are restricted to a small number of a priori 
 selected regions, which could give rise to selection bias.
A method that circumvents this potential bias and allows a 
whole brain, hypothesis-free analysis is voxel-based mor-
phometry (VBM),4 an MRI analysis technique that assesses dif-
ferences between groups in voxelwise grey matter volume. 
Three meta-analyses of VBM studies reporting on partly the 
same samples have investigated the most prominent volumet-
ric differences between participants with ADHD and con-
trols.5–7 The first meta-analysis (114 children with ADHD and 
143 controls) reported smaller grey matter volume in the right 
putamen and globus pallidus in children with ADHD than in 
controls.5 A more recent meta-analysis (202 children and ado-
lescents and 176 adults with ADHD and 344 controls) con-
firmed the reduced localized subcortical grey matter findings 
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Background: Data on structural brain alterations in patients with attention-deficit/hyperactivity disorder (ADHD) have been inconsistent. Both 
ADHD and brain volumes have a strong genetic loading, but whether brain alterations in patients with ADHD are familial has been underex-
plored. We aimed to detect structural brain alterations in adolescents and young adults with ADHD compared with healthy controls. We exam-
ined whether these alterations were also found in their unaffected siblings, using a uniquely large sample. Methods: We performed voxel-
based morphometry analyses on MRI scans of patients with ADHD, their unaffected siblings and typically developing controls. We identified 
brain areas that differed between participants with ADHD and controls and investigated whether these areas were different in unaffected sib-
lings. Influences of medication use, age, sex and IQ were considered. Results: Our sample included 307 patients with ADHD, 169 unaffected 
siblings and 196 typically developing controls (mean age 17.2 [range 8–30] yr). Compared with  controls, participants with ADHD had signifi-
cantly smaller grey matter volume in 5 clusters located in the precentral gyrus, medial and orbitofrontal cortex, and (para)cingulate cortices. Un-
affected siblings showed intermediate volumes significantly different from controls in 4 of these clusters (all except the precentral  gyrus). Medi-
cation use, age, sex and IQ did not have an undue influence on the results.  Limitations: Our sample was heterogeneous, most participants 
with ADHD were taking medication, and the comparison was cross- sectional. Conclusion: Brain areas involved in decision  making, motiva-
tion, cognitive control and motor functioning were smaller in participants with ADHD than in controls. Investigation of unaffected siblings indi-
cated familiality of 4 of the structural brain differences, supporting their potential in molecular genetic analyses in ADHD research.
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in the right globus pallidus and putamen and also reported on 
a smaller right caudate nucleus, whereas larger local grey mat-
ter volume was found in the left posterior cingulate cortex.6 
The most recent study (175 children and adolescents and 
145 adults with ADHD plus 288 controls) found reduced right 
globus pallidus and putamen volumes in children with 
ADHD, whereas the adult samples were characterized by an-
terior cingulate cortex volume reductions.7 However, studies 
used to generate the meta -analyses showed strong heterogene-
ity among samples and methods; reliability analysis revealed 
inconsistency in findings in 50%–75% of the studies.6 Given 
these limitations, investigating local volume differences within 
a single large sample has substantial added value over existing 
meta- analyses.
Mechanisms underlying the association between ADHD and 
brain volumes are unclear. Both ADHD and brain volumes are 
known to be subject to genetic and familial influences (i.e., 
shared genetic and/or shared environmental factors).8,9 This 
suggests the potential usefulness of brain volumes in the search 
for ADHD risk genes.10 In this context, unaffected siblings of 
patients with ADHD are of interest, as they share on average 
50% of their genetic material as well as the family environments 
with the ADHD proband. Consequently, if brain volumes of 
unaffected siblings are also significantly smaller than those of 
healthy controls, this would suggest shared familiality between 
the brain phenotypes and the ADHD phenotype. Two previous 
studies (n = 90 and n = 60, respectively) reported that unaf-
fected siblings of participants with ADHD had alterations in 
prefrontal grey matter and occipital grey and white matter as 
well as inferior frontal gyrus grey matter and inferior fronto- 
occipital fasciculus white matter intermediate between those of 
participants with ADHD and controls,11,12 which indicates a 
shared underlying familial component.
It is important to consider factors that might influence the 
analysis of case–control differences when studying ADHD. 
One of these factors is the use of psychostimulant medication 
in participants with ADHD, with evidence showing that 
stimulant treatment might normalize specific structural brain 
abnormalities found in children with ADHD.13 Two of the 
VBM meta-analyses mentioned previously found that sub-
cortical volume differences between patients with ADHD 
and controls were smaller when the patients had taken medi-
cation.6,7 Further, increasing age was found to be associated 
with smaller brain volume differences6,7 between participants 
with ADHD and controls, which is in line with the findings 
of studies reporting delayed brain maturation in participants 
with ADHD.2,14 As previous MRI studies of ADHD included 
mostly children or adults,5–7 the present study adds to the lit-
erature by focusing on adolescents and young adults. This al-
lows for an examination of the important time window of the 
transition from adolescence into early adulthood when 
studying age effects. It is important to take sex into account, 
because sex distribution in childhood ADHD is skewed, with 
boys outnumbering girls;15 brain volume differs between 
males and females;16 and brain differences in ADHD between 
males and females have been reported.17 In addition, IQ may 
influence associations between brain volume and ADHD be-
cause, on average, children with ADHD tend to have a some-
what lower IQ than controls and because IQ has been associ-
ated with structural brain differences.18
The aim of the present VBM study was 2-fold. First, we 
sought to investigate which brain areas would show case–
control differences using a large sample of adolescents and 
young adults with ADHD and healthy controls. Second, we 
sought to examine whether brain volumetric changes found 
in participants with ADHD relative to controls would also be 
found in the unaffected siblings of participants with ADHD. 
We investigated the potentially confounding role of medica-
tion use, age, sex and IQ on brain volume differences be-
tween participants with ADHD and controls.
Methods
Participants
Participants were recruited from the NeuroIMAGE project, a 
follow-up (2009–2012) of the Dutch part of the International 
Multicentre ADHD Genetics (IMAGE) study performed be-
tween 2003 and 2006.19 In short, ADHD families with at least 
1 child with ADHD and at least 1 biological sibling (regard-
less of ADHD diagnosis) were recruited, as were control fam-
ilies with at least 1 child and 1 biological sibling with no for-
mal or suspected ADHD diagnosis in any of the first-degree 
family members. For references and a detailed description of 
the NeuroIMAGE project and study procedures, see the 
study by von Rhein and colleagues.20
Inclusion criteria were the same for all participants: age be-
tween 8 and 30 years; European Caucasian descent; IQ of 70 
or higher; and no diagnosis of autism, epilepsy, general 
learning difficulties, brain disorders or known genetic disor-
ders. The control families could not have an ADHD diagno-
sis. Participants were excluded from scanning if they had any 
contraindication to scanning. The study was approved by the 
Dutch local medical ethics committees, and after complete 
description of the study to the participants, we obtained writ-
ten informed consent.
Diagnostic assessment of ADHD
To confirm the diagnosis of ADHD at the time of enrollment 
in NeuroIMAGE, all participants were similarly assessed 
 using a combination of a semistructured diagnostic inter-
view and the Conners ADHD questionnaires. Symptom 
counts were taken from these measurements. A detailed de-
scription of diagnostic criteria can be found elsewhere20 and 
in Appendix 1, available at jpn.ca.
Medication
Information on lifetime use of psychoactive medication 
(methylphenidate immediate release, methylphenidate 
 extended release, atomoxetine and dexamphetamine) was 
gathered from pharmacy transcripts and questionnaire re-
ports. We classified individuals who never took medication as 
 medication-naive and compared them to individuals who 
 reported having taken medication during their lifetime.
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IQ
We estimated full-scale IQ by combining scores on 2 subtests 
of the Wechsler Intelligence Scale for Children (WISC; if 
≤ 17 yr) or the Wechsler Adult Intelligence Scale III (WAIS-III; 
if > 17 yr) that show the highest correlations with full-scale 
IQ score: vocabulary and block design.20
Smoking
Self-reported data on smoking status was collected using 
questionnaires. We classified smoking status as ever smoked 
and never smoked.
Imaging data
The MRI scanning was conducted at 2 different locations 
(Donders Centre for Cognitive Neuroimaging in Nijmegen 
and VU University Medical Centre in Amsterdam, the Neth-
erlands) using 2 comparable 1.5 T MRI scanners (Sonata/
Avanto Siemens) and the same 8-channel head-coil and scan 
protocols. For each participant we obtained 2 high-resolution 
T1-weighted magnetization-prepared rapid acquisition with 
gradient echo (MPRAGE) anatomic scans: 1 before and 1 af-
ter a break in a longer scanning session. For participants who 
had 2 good scans, we averaged the VBM estimates across 
both scans, thereby improving the signal-to-noise ratio. If 
only 1 good scan was available, we used a single scan. Each 
participant’s T1-weigthed scan was normalized to Montreal 
Neurological Institute (MNI) 152 standard space, bias-field 
corrected and segmented into grey matter, white matter and 
cerebrospinal fluid using the unified procedure of the VBM 
8.1 toolbox.
Grey matter images were modulated by the nonlinear part 
of the normalization field and smoothed with an 8 mm full-
width at half-maximum Gaussian kernel, providing for an 
analysis of relative differences in regional grey and white 
matter volume, corrected for individual brain size (http 
://dbm.neuro.uni-jena.de/vbm8/VBM8-Manual.pdf). Data 
analysis was restricted to voxels with grey matter with a 
probability exceeding 25%, leading to inclusion of a total of 
230 135 voxels. Details on MRI acquisition and preparation 
can be found in Appendix 1.
Statistical analysis
Inferential statistical analyses were conducted using Stata 
software (StataCorp LP). To investigate case–control differ-
ences in brain volumes, we performed multiple regression 
analyses including the voxelwise grey matter relative volume 
values as outcome measures and binary ADHD diagnosis 
(ADHD v. control) as a main effect. Because of evidence for 
sex effects and linear and quadratic effects of age on brain 
volumes,21,22 the main effects of age, age2 and sex were in-
cluded as covariates. Scanner location (Amsterdam v. Nijme-
gen) was also included as a covariate to account for potential 
effects of site. As observations were not independent within 
families (both the ADHD group and the control group in-
cluded siblings from the same families), we used the “robust 
cluster” option in Stata, which accounts for the correlation 
structure of the data in calculating robust standard errors.23 
We considered differences to be significant if they survived 
cluster-mass thresholding with the easythresh option in FSL 
(www.fmrib.ox.ac.uk/fsl), using an initial cluster forming 
threshold of z > 3.1. Subsequently, we estimated each clus-
ter’s significance level based on Gaussian random field the-
ory, and those clusters surviving a family-wise error (FWE)–
corrected significance threshold of p < 0.05 showing volume 
differences > 0.1 mL were reported. For comparison we re-
peated our main analysis in SPM while not taking into ac-
count the family relatedness in our sample (Appendix 1, 
Fig. S1 and Table S1).
Mean voxel values of each cluster showing case–control 
differences were calculated per individual and entered in a 
linear regression analysis in Stata, accounting for family re-
latedness. Familiarity was considered present if unaffected 
siblings significantly differed in mean voxel values from con-
trols but not from participants with ADHD or if they had 
brain volumes significantly intermediate to participants with 
ADHD and controls.
Possible influence of medication use, age, sex, IQ and 
smoking were carried out as post hoc analyses. As controls 
and unaffected siblings did not use medication, we stratified 
the ADHD group by medication use and compared the mean 
voxel values. To examine age and sex differences, the signifi-
cant clusters were checked for age effects by including age × 
diagnosis, age2 × diagnosis and sex × diagnosis interactions in 
the regression model. This leads to the following regression 
models: Cluster# = βageXage + βage2Xage2 + βsexXsex + βsiteXsite + 
βdiagnosisXdiagnosis + βage×diagnosisXage×diagnosis + clustering on family identi-
fier; Cluster# = βageXage + βage2Xage2 + βsexXsex + βsiteXsite + 
βdiagnosisXdiagnosis + βage2×diagnosisXage2×diagnosis + clustering on family iden-
tifier; and Cluster# = βageXage + βage2Xage2 + βsexXsex + βsiteXsite + 
βdiagnosisXdiagnosis + βsex×diagnosisXsex×diagnosis + clustering on family identi-
fier. To investigate the influence of IQ and smoking, the main 
analysis was repeated adding IQ and smoking separately as 
covariates. Because we had a skewed distribution of our 
groups at the 2 different scan sites, we decided to investigate 
results separately by site. Finally, as symptom counts were 
present in the complete sample and correlated with diagnos-
tic status, associations between symptom counts and brain-
wide brain volume were investigated in the complete sam-
ple. Additionally, analyses on matched subsamples for sex, 
IQ and scan site are described in Appendix 1.
Results
Sample
Our sample included 672 adolescents and young adults and 
comprised 307 participants with ADHD, 169 unaffected sib-
lings of participants with ADHD and 196 controls. The 
ADHD group had a significantly lower IQ than the control 
group (β = –9.1, t356 = –4.78, p < 0.001) and included signifi-
cantly more male than female participants (β = –0.19, t501 = 
–4,39, p < 0.001; Table 1).
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Differences in grey matter volume between participants 
with ADHD and controls
Our whole brain VBM analysis comparing participants with 
ADHD to controls identified 5 clusters in which participants 
with ADHD had significantly smaller grey matter volumes than 
controls. These clusters were located in the precentral gyrus, 
medial and orbitofrontal cortex, frontal pole and paracingulate 
and cingulate cortices (Fig. 1, Table 2 and Appendix 1, Fig. S2).
Differences between unaffected siblings and participants 
with ADHD and between unaffected siblings and controls
For all 5 clusters showing significant case–control differences, 
unaffected siblings showed a pattern of mean voxel volumes 
intermediate to that of the ADHD and control groups (Fig. 1). 
In cluster 1 (precentral gyrus), cluster 2 (orbitofrontal cortex) 
and cluster 3 (frontal pole) the unaffected siblings differed 
significantly from the controls, but not from participants with 
ADHD. In cluster 4 (paracingulate and cingulate cortices, 
frontal pole) all groups significantly differed from each other, 
whereas for cluster 5 (medial frontal, paracingulate, cingulate 
and subcallosal cortices) the unaffected siblings differed sig-
nificantly from the participants with ADHD but not from the 
controls (Table 3).
Possible confounding factors for brain associations
To investigate whether our results were influenced by medi-
cation use, age, sex or IQ, we performed a series of sensitivity 
analyses. No significant differences were observed when the 
mean voxel volumes of the clusters were compared between 
the medicated patients (n = 272) and the never-medicated pa-
tients (n = 35; Appendix 1, Table S2).
The age × diagnosis, age2 × diagnosis and sex × diagnosis 
interaction terms added to the regression models investiga-
ting the differences in mean voxel values between partici-
pants with ADHD and controls were nonsignificant for all 
5 clusters (Appendix 1, Tables S3 and  S4 and Fig. S3).
When we added IQ as a covariate, we identified an addi-
tional significant cluster (171 voxels) in the cuneus for which 
participants with ADHD showed smaller grey matter volume 
than controls. The other 4 significant clusters observed in this 
analysis overlapped with the clusters in the previous analysis 
(Appendix 1, Fig. S4 and Table S5). The cluster in the precen-
tral area was not significant in this analysis. When we added 
smoking status as a covariate, all 5 clusters from the main 
analysis were found again (Appendix 1, Table S6 and Fig. S5).
To investigate whether our results were driven by one of 
the scan sites our main results are plotted per site in Appen-
dix 1, Table S7. Additionally the results for subsamples care-
fully matched on sex, IQ and scan site are described in Ap-
pendix 1, Table S8. Analyses on subsamples matched for sex, 
IQ or scan site revealed the same direction of the neural ef-
fects for all peak voxels.
Differences in grey matter volume with increasing number 
of ADHD symptoms
An additional dimensional analysis of the number of ADHD 
symptoms in the complete sample (ADHD, unaffected sib-
lings and controls) at the whole brain level identified 7 clus-
ters in which more ADHD symptoms were associated with 
significantly smaller grey matter volumes. These clusters 
overlapped with our main analyses and were located in the 
medial and orbitofrontal cortices, frontal pole, paracingulate 
and cingulate cortices. The precentral gyrus cluster reported 
in our main analyses did not show up in the symptom count 
analyses. We found additional clusters in the fusiform gyrus, 
precuneous and frontal operculum (Appendix 1, Table S9).
Discussion
The present study localized alterations of grey matter volume 
in participants with ADHD and examined their underlying 
familial components in a uniquely large sample of adoles-
cents and young adults with ADHD, their unaffected siblings 
and controls. Compared with controls, participants with 
ADHD had smaller grey matter volume in 5 clusters, includ-
ing the left precentral gyrus, medial and left orbitofrontal cor-
tices, frontal pole and paracingulate and cingulate cortices. 
Unaffected siblings exhibited smaller grey matter volumes 
than controls in 4 clusters and showed an overall intermedi-
ate pattern compared with that of participants with ADHD 
Table 1: Demographic and clinical characteristics of study participants
Group; mean ± SD (range)*
Characteristic ADHD, n = 307 Unaffected siblings, n = 169 Controls, n = 196
Age, yr 17.06 ± 3.42 (8–26) 17.52 ± 4.11 (8–30) 16.66 ± 3.07 (9–24)
Male sex, %† 68 43 49
ADHD symptoms 13.16 ± 2.99 1.17 ± 2.20 0.76 ± 1.90
IQ† 97.08 ± 15.18 102.19 ± 14.54 106.61 ± 13.70
Site distribution, site1:site 2 130:177 78:91 120:76
Medication use, ever:never 272:35 — —
No. of scans used, 1:2 39:268 11:158 5:191
ADHD = attention-deficit/hyperactivity disorder; SD = standard deviation.
*Unless indicated otherwise.  
†Differed significantly between participants with ADHD and controls.
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and controls, indicating familial underpinnings. We could 
not detect any effect of medication use or evidence that age, 
sex or IQ had a significant impact on our findings.
Findings in the precentral gyrus, which is linked to motor 
control, and the prefrontal cortex, which is the target of 
ADHD medication,24 are in line with and extend the findings 
of previous VBM studies,25,26 cortical thickness studies27 and 
region of interest studies3 on structural differences in the pre-
central gyrus and prefrontal cortex in individuals with 
ADHD. An important role of abnormalities of the prefrontal 
cortex and its connections in ADHD is indicated.28 However, 
findings in the prefrontal cortex have been inconsistent and 
are not supported by meta- analyses.5–7 A possible contribut-
ing factor is the heterogeneity in age among studies, as de-
velopment of the prefrontal cortex is late and protracted.21
Subtyping of ADHD has been proposed based on dorsal–
frontostriatal, orbitofrontal–striatal and fronto–cerebellar cir-
cuits involved in cognitive control, reward and motivation, 
and timing and building temporal expectations, respec-
tively.29,30 While meta-analyses of VBM studies have shown 
corresponding subcortical regions to be altered in individuals 
with ADHD5–7 and while cerebellar volume differences have 
been reported,3,31 our study did not reveal structural differ-
ences in these regions. Possible explanations for this might be 
the adolescent age range of our sample and the previously re-
ported normalization of differences in caudate nucleus volume 
Fig. 1: (A) Whole-brain significant clusters for case–control differences. Five clusters were identified: cluster 1 = precentral gyrus; cluster 2 = orbi-
tofrontal cortex; cluster 3 = frontal pole; cluster 4 = paracingulate and cingulate cortices, frontal pole; and cluster 5  = medidal frontal, paracingu-
late, cingulate and subcallosal cortices. (B) Mean voxel differences for the identified cluster between participants with attention-deficit/ 
hyperactivity disorder (ADHD; n = 307), their unaffected siblings (n = 169) and typically developing controls (n = 196).
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with age where other brain abnormalities between participants 
with ADHD and controls persisted during development.2 
Also, medication use might have contributed to the absence of 
findings for subcortical structures.6 However, a meta-analysis 
on manual tracing studies of subcortical structures did find 
mean differences in caudate nucleus volume even without 
findings in VBM.7 A volumetric study segmenting the com-
plete volume of the caudate nucleus and the putamen in the 
present sample also showed differences in both to be present.32 
Such findings could indicate that the differences in caudate nu-
cleus and putamen volume in individuals with ADHD are dis-
persed as opposed to localized to the very same cluster of vox-
els and hence not easily detected with VBM.
To date, brain volumetric studies in individuals with 
ADHD have only rarely included unaffected siblings.11,12 
Our findings in a larger sample including both adolescents 
and adults provide important insight into the familial 
 underpinnings of structural brain differences in individuals 
with ADHD. Familial components can in theory be due to 
shared genetic and/or shared environmental factors. Since 
there is strong evidence for familial components of ADHD 
to be largely genetic,9,33 we hypothesize the familial effects 
in the reported brain areas to be mainly driven by genetic 
factors. Of relevance, a twin study investigating voxel-
based brain volume in high- and low–ADHD risk concord-
ant or discordant twin pairs reported genetically mediated 
risk for ADHD in the medial orbitofrontal areas;34 this 
 finding overlaps with our results. If confirmed, the identi-
fied areas may prove useful in molecular genetic research 
on ADHD.
We investigated whether medication use, age, sex or IQ in-
fluenced our results. Null findings for medication use might 
have been due to power limitations, as the majority of our 
ADHD group had used medication. This fact might also have 
influenced our results (i.e., based on meta-analytic results, 
smaller case–control differences can be expected with medi-
cation use6). The findings from our analyses show develop-
mentally stable smaller grey matter volume in frontal brain 
areas and thereby suggest a deviant development of these 
brain areas as supposed to a delayed development in partici-
pants with ADHD. Findings from our analyses in a rather 
large sample of participants aged 8–30 years indicate that in-
dividuals with ADHD do not “catch up” their delay in brain 
volume differences in the reported clusters, but rather remain 
different from healthy controls. As developmental delay has 
been suggested and reported in prefrontal areas of the brain 
in individuals with ADHD,14 longitudinal studies are war-
ranted to investigate whether these changes remain through-
out adulthood. Although we had a sex distribution imbal-
ance in our sample, post hoc analyses did not indicate that 
our results are driven by sex-specific differences.
When including IQ in the analysis, the precentral gyrus 
finding was no longer significant, and an additional region 
in the cuneus reached significance. To our knowledge, 
Table 3: Mean voxel values comparisons for participants with ADHD, their unaffected siblings and controls










Cluster 1 0.016 0.016 0.18 0.003  < 0.001 0.034 0.494 ± 0.0652 0.477 ± 0.0686 0.468 ± 0.0626
Cluster 2 0.003 0.027 0.10 0.005  < 0.001 0.049 0.661 ± 0.0723 0.639 ± 0.0686 0.628 ± 0.0723
Cluster 3 0.007 0.022 0.09 0.006  < 0.001 0.043 0.412 ± 0.0573 0.396 ± 0.0568 0.388 ± 0.0590
Cluster 4 0.034 0.041 0.007 0.016  < 0.001 0.052 0.504 ± 0.0544 0.492 ± 0.0576 0.478 ± 0.0562
Cluster 5 0.21 0.004 0.004 0.016  < 0.001 0.037 0.664 ± 0.0823 0.653 ± 0.0833 0.632 ± 0.0762
ADHD = attention-deficit/hyperactivity disorder; C–A = mean volume differences between controls and ADHD; C–U = mean volume differences between controls and 
unaffected siblings; U–A = mean volume differences between unaffected siblings and ADHD; SD = standard deviation. 
*Effect sizes (R2) are based on mean cluster comparisons using robust cluster regression in Stata software after regressing out age, age2, sex and scanner site. 










Cl 1 157 –40, –6, 56 –3.96 L Precentral gyrus
Cl 2 244 –26, 16, –24 –4.43 L Orbitofrontal cortex
Cl 3 250 28, 70, –2 –4.17 R Frontal pole
Cl 4 518 –14, 52, 14 –4.43 L Paracingulate cortex, 
cingulate cortex, frontal 
pole
Cl 5 667 2, 22, –2 –3.79 L, R Medial frontal, 
paracingulate, cingulate 
and subcallosal cortices
ADHD = attention-deficit/hyperactivity disorder; Cl = cluster; L = left; R = right; VBM = voxel-based morphometry. 
*Smaller volume in participants with ADHD compared with controls. 
†MNI coordinates are provided in mm for the peak voxel.
‡Reported areas are identified with the Harvard Oxford cortical and subcortical structural atlases. 
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 volumetric differences in the cuneus have not been re-
ported previously in ADHD samples; however, an associ-
ation between inattentive symptoms and resting state ac-
tivitity in the cuneus have recently been shown.35 The 
cuneus finding was subthreshold in our main analysis 
and also became apparent in the analysis that was not 
corrected for family structure (Appendix 1). There is an 
active debate whether IQ needs to be included as a co-
variate in investigations of ADHD.36 Individuals with 
ADHD have an IQ that is generally about 10 points lower 
than in healthy participants,37 which could argue in fa-
vour of including IQ as a covariate. However, IQ might 
share meaningful variance with ADHD,19 at least par-
tially, and therefore covarying for IQ might lead to an 
overcorrection. In the present study, both analyses are 
provided. The overlapping results of our main analyses 
and the dimensional analysis on symptom counts are in 
line with the view of ADHD as an extreme on a con-
tinu um of behaviour.38 By using dimensional data, span-
ning the range from normal to abnormal, knowledge can 
be gained on how constructs are related to disorders. For 
all reported clusters an increase in symptom counts was 
related to smaller volume, which is in line with the find-
ings of previous studies reporting reduced brain volume 
with increasing ADHD severity.39,40
Limitations
Our findings should be viewed in light of strengths and 
limitations. We improved upon previous studies by in-
cluding a large sample, including unaffected siblings, and 
both adolescents and young adults. Another strength is 
the use of a whole brain, hypothesis-free approach. As the 
present study consisted of a large naturalistic group of 
participants with ADHD and controls, differences in IQ 
and sex were present in our sample, which is frequently 
the case in studies of ADHD.15,19 Similarly, most of the par-
ticipants with ADHD had used medication. An alternative 
approach to the sensitivity analyses presented would have 
been to specify groups before analysis (e.g., by investigat-
ing only medication-naive participants with ADHD 
matched to controls by age, sex, IQ and psychiatric comor-
bidity),31 but the trade-off would have been a smaller sam-
ple size consisting of atypical ADHD cases. Head move-
ment is an important topic in ADHD research. Hence, we 
performed several steps to minimize movement during 
scanning and carefully assessed data quality for any po-
tential movement-related artifacts.20 Additionally, we col-
lected 2 structural MRI scans, quality-controlled all of 
them and excluded scans with excessive motion. For par-
ticipants with 2 good scans, estimated volumes were aver-
aged across scans to improve signal-to-noise ratio. As 
2 scan sites were used for data collection, we included scan 
site as a covariate in our main analyses; however, this lin-
ear correction might not be sufficient. Post hoc analyses 
matched by scan site and replicating findings separately 
within each scan site suggest that our results were not 
driven by scan site–specific differences.
Conclusion
Several lines of future research follow from the present study. 
First, longitudinal studies are warranted to properly investi-
gate developmental trajectories of brain differences in individ-
uals with ADHD. Second, molecular genetic analyses on brain 
phenotypes with familial underpinnings can aid the search 
for and understanding of genetic risk factors for ADHD. 
The present VBM analysis of MRI scans in a large sample 
of participants with ADHD, unaffected siblings and controls 
found that ADHD was associated with smaller grey matter 
volume in frontal and precentral areas of the cortex, involv-
ing decision making, executive functioning and motor func-
tioning areas. The identified clusters are potentially linked to 
familial risk for ADHD.
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